Yves Gillet

Yves Gillet is an experienced investment professional currently serving as an investor for multiple companies, including Oria Bioscience, inHEART, Avatar Medical, Pandobac, and Kard. In addition to these roles, Yves Gillet holds the position of President at RioPargo, a role undertaken since March 2021. Prior to this, Yves Gillet had an extensive tenure at Essilor from January 2005 to February 2021, where responsibilities included Vice President of Operations Greater China, Vice President of Asia Operations, and Managing Director.